38573604,38557775,38566053,38332179,38576352,38577716,38571449,38579107,38578513,38572567,38572548,38567630,38557285,38575670[uid] - Search Results

1

Marçais A. Marçais A. Blood. 2024 Apr 4;143(14):1320-1322. doi: 10.1182/blood.2023023714. Blood. 2024. PMID: 38573604 No abstract available.

2

Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.

Locke FL, Oluwole OO, Kuruvilla J, Thieblemont C, Morschhauser F, Salles GA, Rowe SP, Vardhanabhuti S, Winters J, Filosto S, To C, Cheng P, Schupp M, Korn R, Kersten MJ. Locke FL, et al. Blood. 2024 Apr 1:blood.2023021620. doi: 10.1182/blood.2023021620. Online ahead of print. Blood. 2024. PMID: 38557775

3

Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR.

Zhong Y, Tan GW, Bult J, Veltmaat N, Plattel W, Kluiver J, Enting R, Diepstra A, van den Berg A, Nijland M. Zhong Y, et al. BMC Cancer. 2024 Apr 2;24(1):407. doi: 10.1186/s12885-024-12191-z. BMC Cancer. 2024. PMID: 38566053 Free PMC article.

4

Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.

Abrahão R, Brunson A, Ruddy KJ, Li Q, Li J, Ryder MM, Chubak J, Nichols HB, Sauder CAM, Gray MF, Hahn EE, Wun T, Keegan THM. Abrahão R, et al. Br J Cancer. 2024 Apr;130(7):1166-1175. doi: 10.1038/s41416-024-02594-x. Epub 2024 Feb 8. Br J Cancer. 2024. PMID: 38332179

5

Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.

Roccuzzo G, Calvão J, Dobos G, Morsia E, Mozas P, Peterknecht E, Schrader AMR, Zottarelli F, Bagot M, Stadler R, Vermeer M, Quaglino P, Scarisbrick J. Roccuzzo G, et al. Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093/bjd/ljae145. Online ahead of print. Br J Dermatol. 2024. PMID: 38576352 No abstract available.

6

Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation.

Atallah-Yunes SA, Habermann TM, Khurana A. Atallah-Yunes SA, et al. Br J Haematol. 2024 Apr 5. doi: 10.1111/bjh.19425. Online ahead of print. Br J Haematol. 2024. PMID: 38577716 Review.

7

Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis.

Milrod CJ, Kim KW, Raker C, Ollila TA, Olszewski AJ, Pelcovits A. Milrod CJ, et al. Br J Haematol. 2024 Apr 4. doi: 10.1111/bjh.19449. Online ahead of print. Br J Haematol. 2024. PMID: 38571449

8

Body composition and late-occurring chronic health conditions after autologous stem cell transplantation for lymphoma.

Giri S, Harmon C, Landier W, Chen Y, Wu J, Hageman L, Balas N, Francisco L, Bosworth A, Weisdorf DJ, Forman SJ, Armenian SH, Williams GR, Bhatia S. Giri S, et al. Cancer. 2024 Apr 5. doi: 10.1002/cncr.35298. Online ahead of print. Cancer. 2024. PMID: 38579107

9

Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma.

Liu Y, Li Y, Zhang C, Yang X, Yang B, Cheng J, Chen J, Yuan X, Li Y, Chen Y, Zhang F, Tang D, He Z, Wang F. Liu Y, et al. Discov Oncol. 2024 Apr 5;15(1):105. doi: 10.1007/s12672-024-00965-7. Discov Oncol. 2024. PMID: 38578513 Free PMC article.

10

Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes.

Bourlon C, Roddie C, Menne T, Norman J, O'Reilly M, Gibb A, Besley C, Chaganti S, Arias CG, Jones C, Dikair A, Allen S, Seymour F, Osborne W, Mathew A, Townsend W, Patten PE, Thoulouli E, Abdulgawad A, Lugthart S, Sanderson R, Kirkwood AA, Kuhnl A. Bourlon C, et al. Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2024.285010. Online ahead of print. Haematologica. 2024. PMID: 38572567 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page